Christine E Engeland

7PUBLICATIONS
18CO-AUTHORS
Molecular targetsPredictive and prognostic markersHaematological tumoursCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Feb 28, 2023
Oncolytic Measles Virus Encoding MicroRNA for Targeted RNA Interference.

Sophie C Anker, Marie G Szczeponik, Jan Dessila

|Feb 10, 2023
A vector-encoded bispecific killer engager to harness virus-activated NK cells as anti-tumor effectors.

Alessia Floerchinger, Jessica E Klein, Maximiliane S C Finkbeiner

|Aug 28, 2021
Virotherapy in Germany-Recent Activities in Virus Engineering, Preclinical Development, and Clinical Studies.

Dirk M Nettelbeck, Mathias F Leber, Jennifer Altomonte

|Aug 24, 2021
Phase 2 Trial of Oncolytic H-1 Parvovirus Therapy Shows Safety and Signs of Immune System Activation in Patients With Metastatic Pancreatic Ductal Adenocarcinoma.

Jacek Hajda, Barbara Leuchs, Assia L Angelova

|Apr 17, 2021
Oncolytic viruses encoding bispecific T cell engagers: a blueprint for emerging immunovirotherapies.

Johannes P W Heidbuechel, Christine E Engeland

|Feb 04, 2021
Measles Virus as an Oncolytic Immunotherapy.

Christine E Engeland, Guy Ungerechts

Pageof 2

Frequent Collaborators

2 joint publications

Mathias F Leber

1 joint publications

Stefan B Eichmüller

1 joint publications

Jacek Hajda

1 joint publications

Jean Rommelaere